Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Roswell Park Cancer Institute Corporation. Div. of Pathology
FDA Inspection
•Roswell Park Cancer Institute Corporation. Div. of Pathology•June 17, 2011

Roswell Park Cancer Institute Corporation. Div. of Pathology – FDA Inspection, Jun 17, 2011

Record Details

This FDA Inspection record concerns Roswell Park Cancer Institute Corporation. Div. of Pathology, with an inspection on June 17, 2011, issued by the Center for Biologics Evaluation and Research, covering biologics.

Company
Roswell Park Cancer Institute Corporation. Div. of Pathology
Inspection Date
June 17, 2011
Product Type
Biologics
Office
Center for Biologics Evaluation and Research
View Company Profile

ID · 30483b1c-39cf-4a67-ae27-4da16dda57aa

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
730322
FDA center
Biologics
Project area
Blood and Blood Products

FDA Citations

4
  1. 21 CFR 211.194(a)(8)Second person sign off
  2. 21 CFR 211.194(a)(7)Signatures and dates--person who performs test
  3. 21 CFR 211.100(b)SOPs not followed / documented
  4. 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Roswell Park Cancer Institute Corporation. Div. of Pathology

7
DateClassificationOfficeProject area
September 19, 2025NAICenter for Biologics Evaluation and ResearchHuman Cellular, Tissue, and Gene Therapies
March 13, 2023NAICenter for Biologics Evaluation and ResearchHuman Cellular, Tissue, and Gene Therapies
March 1, 2019NAICenter for Biologics Evaluation and ResearchBlood and Blood Products
January 13, 2017NAICenter for Biologics Evaluation and ResearchBlood and Blood Products
December 19, 2014NAICenter for Biologics Evaluation and ResearchBlood and Blood Products
View all 7 other inspections on the company page
Other documents for Roswell Park Cancer Institute Corporation. Div. of Pathology
  • FDA Inspection 1284298 - 2025-09-19
  • FDA Inspection 1200624 - 2023-03-13
  • FDA Inspection 1084076 - 2019-03-01
  • FDA Inspection 998259 - 2017-01-13
  • FDA Inspection 908088 - 2014-12-19

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Roswell Park Cancer Institute Corporation. Div. of Pathology
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.